Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes Research Letter


Authors: Paudel, B. B.; Tan, S. F.; Fox, T. E.; Ung, J.; Golla, U.; Shaw, J. J. P.; Dunton, W.; Lee, I.; Fares, W. A.; Patel, S.; Sharma, A.; Viny, A. D.; Barth, B. M.; Tallman, M. S.; Cabot, M.; Garrett-Bakelman, F. E.; Levine, R. L.; Kester, M.; Feith, D. J.; Claxton, D.; Janes, K. A.; Loughran, T. P. Jr
Title: Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes
Keywords: gene mutation; human cell; overall survival; flow cytometry; letter; mass spectrometry; gene; gene expression; cytogenetics; tumor xenograft; immunoreactivity; transcriptomics; fluorescence in situ hybridization; bone marrow cell; leukocyte count; karyotype; immunocompetent cell; lymphocyte count; glucose metabolism; acute myeloid leukemia; sphingolipid; support vector machine; lipidomics; human
Journal Title: Blood Advances
Volume: 8
Issue: 5
ISSN: 2473-9529
Publisher: American Society of Hematology  
Date Published: 2024-03-12
Start Page: 1137
End Page: 1142
Language: English
DOI: 10.1182/bloodadvances.2023010535
PUBMED: 38170742
PROVIDER: scopus
PMCID: PMC10909712
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    775 Levine